Justin Sullivan/Getty Images News
- Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) priced senior unsecured notes in an aggregate principal amount of $3.5B, in an underwritten, registered public offering.
- The offering consists of $750M of 4.80% senior notes maturing in 2029, $1B of 5.10% senior notes maturing in 2035, $1B of 5.50% senior notes maturing in